First clinical trial of nitinol self-expanding everolimus-eluting stent implantation for peripheral arterial occlusive disease

Journal of Vascular Surgery

Volumn 54, Issue 2, 2011, Pages 394-401

  Lammer, Johannes ^a   Bosiers, Marc ^b   Zeller, Thomas ^c   Schillinger, Martin ^a   Boone, Els ^d   Zaugg, Margo J ^d   Verta, Patrick ^d   Peng, Lei ^d   Gao, Xingyu ^d   Schwartz, Lewis B ^d  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b AZ Street Blasius ^*  (Belgium)

^c UNIVERSITY HEART CENTER FREIBURG BAD KROZINGEN   (Germany)

^d ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ETHYLENE VINYL ALCOHOL COPOLYMER; EVEROLIMUS; HEPARIN; NITINOL; THIENOPYRIDINE DERIVATIVE;

ADULT; AGED; ANGINA PECTORIS; ANTICOAGULANT THERAPY; ARTERIOGRAPHY; ARTHRALGIA; ARTICLE; BACKACHE; BELOW KNEE AMPUTATION; BLOOD CLOTTING DISORDER; CARCINOMA; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COLON RESECTION; CONGESTIVE CARDIOMYOPATHY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DRUG ELUTING STENT; ECHOGRAPHY; FALSE ANEURYSM; FEMALE; FEVER; FOLLOW UP; GASTROINTESTINAL DISEASE; GASTROINTESTINAL HEMORRHAGE; HEMATOMA; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; IN-STENT RESTENOSIS; INFECTIOUS COMPLICATION; LIMB ISCHEMIA; LOW DRUG DOSE; LUNG EDEMA; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT SAFETY; PERIPHERAL NEUROPATHY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PNEUMONIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT DISEASE; STROKE; SUPERFICIAL FEMORAL ARTERY; THROMBOSIS; WOUND HEALING IMPAIRMENT;

AGED; ANGIOPLASTY; ANKLE BRACHIAL INDEX; CARDIOVASCULAR AGENTS; CONSTRICTION, PATHOLOGIC; DRUG-ELUTING STENTS; EUROPE; FEMALE; FEMORAL ARTERY; HUMANS; KAPLAN-MEIER ESTIMATE; LIMB SALVAGE; MALE; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; POPLITEAL ARTERY; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; SEVERITY OF ILLNESS INDEX; SIROLIMUS; TIME FACTORS; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER, DUPLEX; VASCULAR PATENCY;

EID: 79961172699     PISSN: 07415214     EISSN: 10976809     Source Type: Journal    
DOI: 10.1016/j.jvs.2011.01.047     Document Type: Article

References (35)

1. L. Norgren, W.R. Hiatt, J.A. Dormandy, M.R. Nehler, K.A. Harris, and F.G.R. Fowkes Inter-society consensus for the management of peripheral arterial disease (TASC) II) J Vasc Surg 45 Suppl S 2007 S5A S67A
2. M.J. Pentecost, M.H. Criqui, G. Dorros, J. Goldstone, K.W. Johnston, and E.C. Martin Guidelines for peripheral percutaneous transluminal angioplasty of the abdominal aorta and lower extremity vessels A statement for health professionals from a Special Writing Group of the Councils on Cardiovascular Radiology, Arteriosclerosis, Cardio-Thoracic and Vascular Surgery, Clinical Cardiology, and Epidemiology and Prevention, the American Heart Association J Vasc Interv Radiol 14 2003 S495 S515
3. D.J. Adam, J.D. Beard, T. Cleveland, J. Bell, A.W. Bradbury, J.F. Forbes BASIL trial participants Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial Lancet 366 2005 1925 1934 (Pubitemid 41713982)
4. M. Schillinger, S. Sabeti, C. Loewe, D. Petra, A. Jasmin, and M. Wolfgang Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery New Engl J Med 354 2006 1879 1888 (Pubitemid 43872689)
5. A.T. Hirsch, Z.J. Haskal, N.R. Hertzer, C.W. Bakal, M.A. Creager, and J.L. Halperin ACC/AHA, Guidelines for the management of patients with peripheral arterial disease; 2005 (lower extremity, renal, mesenteric, and abdominal aortic): executive summary A collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (writing committee to develop guidelines for the management of patients with peripheral arterial disease) J Am Coll Cardiol 2006 1239 1312
6. P.W. Serruys, M.J.B. Kutryk, and A.T.L. Ong Coronary-artery stents New Engl J Med 354 2006 483 495 (Pubitemid 43200299)
7. S.H. Duda, B. Pusich, G. Richter, P. Landwehr, V.L. Oliva, and A. Tielbeek Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-months results Circulation 106 2002 1505 1509
8. S.H. Duda, M. Bosiers, J. Lammer, D. Scheinert, T. Zeller, and A. Tielbeek Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II Trial J Vasc Interv Radiol 16 2005 331 338 (Pubitemid 40354849)
9. D. Scheinert, M. Ulrich, S. Scheinert, J. Sax, S. Braunlich, and G. Biamino Comparison of sirolimus-eluting vs. bare-metal stents for the treatment of infrapopliteal obstructions Eurointerv 2 2006 169 174
10. S.H. Duda, M. Bosiers, J. Lammer, D. Scheinert, T. Zeller, and V. Oliva Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial J Endovasc Ther 13 2006 701 710 (Pubitemid 44907633)
11. O. Schlager, D. Petra, S. Schila, A. Jasmin, M. Wolfgang, and M. Erich Long-segment SFA stenting -the dark sides: in-stent restenosis, clinical deterioration, and stent fractures J Endovasc Ther 12 2005 676 684 (Pubitemid 43100925)
12. M. Schillinger, S. Sabeti, P. Dick, J. Amighi, W. Mlekusch, and O. Schlager Sustained benefit at two years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting Circulation 115 2007 2745 2749 (Pubitemid 46842791)
13. C. Dunn, and K.F. Croom Everolimus: a review of its use in renal and cardiac transplantation Drugs 66 2006 547 570
14. R.J. Motzer, B. Escudier, S. Oudard, T.E. Hutson, C. Porta, and S. Bracarda Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial Lancet 372 2008 449 456
15. A.J. Carter, A. Brodeur, R. Collingwood, S. Ross, L. Gibson, and C.-A. Wang Experimental efficacy of an everolimus eluting cobalt chromium stent Cath Cardiovasc Interv 68 2006 97 103 (Pubitemid 44024469)
16. R. Waksman, R. Pakala, R. Baffour, D. Hellinga, R. Seabron, and F. Kolodgie Optimal dosing and duration of oral everolimus to inhibit in-stent neointimal growth in rabbit iliac arteries Cardiovasc Revasc Med (CRM) 7 2006 179 184 (Pubitemid 44292070)
17. G.W. Stone, M. Midei, W. Newman, M. Sanz, J.B. Hermiller, and J. Williams Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial JAMA 299 2008 1903 1913 (Pubitemid 351574920)
18. T. Cicchetti, R.P. Senatore, F. Frandina, S. Ferrari, U. Striano, and M. Milei Dialysis treatment using an ethylene vinyl alcohol membrane and no anticoagulation for chronic uremic patients Artif Organs 17 1993 816 819 (Pubitemid 23288695)
19. M. Ayad, E. Eskiglu, and M.R.A. Onyx A unique neuroembolic agent Expert Rev Med Dev 3 2006 705 715
20. J.W. Moses, M.B. Leon, J.J. Popma, P.J. Fitzgerald, D.R. Holmes, and C. O'Shaughnessy Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery New Engl J Med 349 2003 1315 1323 (Pubitemid 37186209)
21. L.B. Schwartz Drug-eluting stents and their application to the peripheral arteries The Society of Vascular Surgery Vascular Annual Meeting 2007 Baltimore, Maryland
22. M.D. McDermott, K. Liu, J.M. Guralnik, G.J. Martin, M.H. Criqui, and P. Greenland Measurement of walking endurance and walking velocity with questionnaire: Validation of the walking impairment questionnaire in men and women with peripheral arterial disease J Vasc Surg 28 2009 1072 1081
23. R.B. Rutherford, J.D. Baker, C. Ernst, K.W. Johnston, J.M. Porter, and S. Ahn Recommended standards for reports dealing with lower extremity ischemia: revised version J Vasc Surg 26 1997 517 538 (Pubitemid 27408567)
24. N. Diehm, P.M. Pattynama, M.R. Jaff, A. Cremonesi, G.J. Becker, and L.N. Hopkins Clinical endpoints in peripheral endovascular revascularization trials: a case for standardized definitions Eur J Vasc Endovasc Surg 36 2008 409 419
25. R.A. Costa, A.J. Lansky, E. Cristea, M. Bosiers, J. Lammer, and D. Scheinert Angiographic analysis of stent fracture in superficial femoral artery (SFA) or proximal popliteal artery lesions treated with the S.M.A.R.T. nitinol self-expanding stent and relationship to adverse clinical events Am J Cardiol 96 Suppl 7A 2005 20H
26. D. Scheinert, S. Scheinert, J. Sax, C. Piorkowski, S. Brunlich, and M. Ulrich Prevalence and clinical impact of stent fractures after femoropopliteal stenting J Am Coll Cardiol 45 2005 312 315 (Pubitemid 40094743)
27. O. Iida, S. Nanto, M. Uematsu, T. Morozumi, J.-i. Kotani, and M. Awata Effect of exercise on frequency of stent fracture in the superficial femoral artery Am J Cardiol 98 2006 272 274 (Pubitemid 43975509)
28. D.E. Allie, C.J. Hebert, and C.M. Walker Nitinol stent fractures in the SFA: the biomechanical forces exerted on the SFA provide a "stiff" challenge to endovascular stenting Endovasc Today 7 2004 1 8
29. D.J. Clark, S. Lessio, M. O'Donoghue, C. Tsalamandris, R. Schainfeld, and K. Rosenfield Mechanisms and predictors of carotid artery stent restenosis: a serial intravascular ultrasound study J Am Coll Cardiol 47 2006 2390 2396 (Pubitemid 43866374)
30. G.W. Stone, S.G. Ellis, D.A. Cox, J. Hermiller, C. O'Shaughnessy, and J.T. Mann A polymer-based paclitaxel-eluting stent in patients with coronary artery disease N Engl J Med 350 2004 221 231 (Pubitemid 38067635)
31. J. Fajadet, W. Wijns, G.-J. Laarman, K.-H. Kuck, J. Ormiston, and T. Mnzel Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions: clinical and angiographic results of the ENDEAVOR II trial Circulation 114 2006 798 806 (Pubitemid 44268230)
32. H. Krankenberg, M. Schlter, H.J. Steinkamp, K. Brgelin, D. Scheinert, and K.-L. Schulte Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the Femoral Artery Stenting Trial (FAST) Circulation 116 2007 285 292 (Pubitemid 47196564)
33. D.M. Ihnat, S.T. Duong, Z.C. Taylor, L.R. Leon, J.L. Mills Sr, and K.R. Goshima Contemporary outcomes after superficial femoral artery angioplasty and stenting: the influence of TASC classification and runoff score J Vasc Surg 47 2008 967
34. M. Bosiers, G. Torsello, H.-M. Giβler, J. Ruef, S. Muller-Hulsbeck, and T. Jahnke Nitinol stent implantation in long superficial femoral artery lesions: 12-month results of the DURABILITY I study J Endovasc Ther 16 2009 261 269
35. O. Iida, S. Nanto, M. Uematsu, K. Ikeoka, S. Okamoto, and S. Nagata Influence of stent fracture on the long-term patency in the femoro-popliteal artery J Am Coll Cardiol Interv 2 2009 665 671